Showing results (181-190 of 218) with videos related to

Sort By:
Pageof 22
Nature Communications|September 22, 2020
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritisFrank Penkava, Martin Del Castillo Velasco-Herrera, Matthew D Young, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogrammingFaye A H Cooles, Jessica Tarn, Dennis W Lendrem, et al.
Annals of the Rheumatic Diseases|April 24, 2026
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, et al.
Lancet (London, England)|February 16, 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.
Ebiomedicine|November 13, 2022
Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunityJames I Robinson, Md Yuzaiful Md Yusof, Vinny Davies, et al.
Annals of the Rheumatic Diseases|February 6, 2021
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19Alessia Alunno, Aurélie Najm, Pedro M Machado, et al.
Frontiers in Medicine|March 29, 2021
SARS-CoV-2 Testing of 11,884 Healthcare Workers at an Acute NHS Hospital Trust in England: A Retrospective AnalysisAidan T Hanrath, Ina Schim van der Loeff, Dennis W Lendrem, et al.
JCI Insight|May 8, 2019
Keratinocyte growth factor impairs human thymic recovery from lymphopeniaAlasdair J Coles, Laura Azzopardi, Onajite Kousin-Ezewu, et al.
Annals of the Rheumatic Diseases|May 13, 2022
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseasesCharlotte Lm Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, et al.
Pageof 22